Nyxoah (NYXH) Competitors $5.98 0.00 (0.00%) Closing price 04/15/2025 04:00 PM EasternExtended Trading$6.03 +0.05 (+0.77%) As of 04/15/2025 06:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NYXH vs. AXGN, EMBC, BVS, RXST, CBLL, IRMD, AVNS, SIBN, KIDS, and BFLYShould you be buying Nyxoah stock or one of its competitors? The main competitors of Nyxoah include AxoGen (AXGN), Embecta (EMBC), Bioventus (BVS), RxSight (RXST), CeriBell (CBLL), Iradimed (IRMD), Avanos Medical (AVNS), SI-BONE (SIBN), OrthoPediatrics (KIDS), and Butterfly Network (BFLY). These companies are all part of the "medical equipment" industry. Nyxoah vs. AxoGen Embecta Bioventus RxSight CeriBell Iradimed Avanos Medical SI-BONE OrthoPediatrics Butterfly Network AxoGen (NASDAQ:AXGN) and Nyxoah (NASDAQ:NYXH) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, risk, community ranking, earnings, profitability, valuation, dividends and institutional ownership. Do analysts recommend AXGN or NYXH? AxoGen currently has a consensus target price of $22.60, suggesting a potential upside of 44.41%. Nyxoah has a consensus target price of $14.75, suggesting a potential upside of 146.66%. Given Nyxoah's higher possible upside, analysts plainly believe Nyxoah is more favorable than AxoGen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AxoGen 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00Nyxoah 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more risk & volatility, AXGN or NYXH? AxoGen has a beta of 1, indicating that its stock price has a similar volatility profile to the S&P 500.Comparatively, Nyxoah has a beta of 1.55, indicating that its stock price is 55% more volatile than the S&P 500. Is AXGN or NYXH more profitable? AxoGen has a net margin of -7.91% compared to Nyxoah's net margin of -1,043.93%. AxoGen's return on equity of -14.91% beat Nyxoah's return on equity.Company Net Margins Return on Equity Return on Assets AxoGen-7.91% -14.91% -7.49% Nyxoah -1,043.93%-51.68%-40.11% Does the MarketBeat Community prefer AXGN or NYXH? AxoGen received 416 more outperform votes than Nyxoah when rated by MarketBeat users. However, 73.21% of users gave Nyxoah an outperform vote while only 72.89% of users gave AxoGen an outperform vote. CompanyUnderperformOutperformAxoGenOutperform Votes45772.89% Underperform Votes17027.11% NyxoahOutperform Votes4173.21% Underperform Votes1526.79% Which has better valuation and earnings, AXGN or NYXH? AxoGen has higher revenue and earnings than Nyxoah. AxoGen is trading at a lower price-to-earnings ratio than Nyxoah, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAxoGen$187.34M3.70-$21.72M-$0.22-71.14Nyxoah$4.52M45.05-$46.77M-$1.95-3.07 Do insiders and institutionals hold more shares of AXGN or NYXH? 80.3% of AxoGen shares are held by institutional investors. 7.0% of AxoGen shares are held by company insiders. Comparatively, 17.1% of Nyxoah shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the media prefer AXGN or NYXH? In the previous week, AxoGen had 1 more articles in the media than Nyxoah. MarketBeat recorded 8 mentions for AxoGen and 7 mentions for Nyxoah. AxoGen's average media sentiment score of 1.29 beat Nyxoah's score of 0.31 indicating that AxoGen is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AxoGen 6 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Nyxoah 0 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryAxoGen beats Nyxoah on 11 of the 17 factors compared between the two stocks. Remove Ads Get Nyxoah News Delivered to You Automatically Sign up to receive the latest news and ratings for NYXH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NYXH vs. The Competition Export to ExcelMetricNyxoahSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$203.68M$4.06B$5.33B$7.57BDividend YieldN/A39.50%5.11%4.32%P/E Ratio-3.2027.6321.7317.81Price / Sales45.0550.20379.2094.61Price / CashN/A51.0838.1534.64Price / BookN/A5.826.464.00Net Income-$46.77M$67.09M$3.20B$247.23M7 Day Performance-4.17%-0.17%2.85%1.45%1 Month Performance-43.10%-3.20%-8.55%-6.24%1 Year Performance-35.70%14.84%10.46%0.60% Nyxoah Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NYXHNyxoah2.0579 of 5 stars$5.98flat$14.75+146.7%-32.8%$203.68M$4.52M-3.20110Short Interest ↑Gap DownAXGNAxoGen2.9597 of 5 stars$16.62+2.5%$22.60+36.0%+122.6%$737.00M$187.34M-51.94450Short Interest ↑News CoveragePositive NewsGap DownEMBCEmbecta4.5228 of 5 stars$12.09+0.8%$23.00+90.2%+12.5%$702.84M$1.11B12.091,900Gap DownHigh Trading VolumeBVSBioventus3.1717 of 5 stars$8.27-0.7%$15.00+81.4%+67.2%$677.68M$573.28M-13.561,200News CoveragePositive NewsGap DownRXSTRxSight3.0248 of 5 stars$16.61+2.2%$43.78+163.6%-72.5%$672.56M$139.93M-20.01220Analyst ForecastGap DownHigh Trading VolumeCBLLCeriBellN/A$18.19-1.4%$32.50+78.7%N/A$652.44M$65.44M0.00N/ANews CoverageGap DownIRMDIradimed4.8759 of 5 stars$49.37-1.1%$72.00+45.8%+27.1%$627.74M$73.24M32.91110Short Interest ↓News CoveragePositive NewsAVNSAvanos Medical3.1827 of 5 stars$12.88-4.0%N/A-36.1%$592.43M$687.80M37.884,040Positive NewsHigh Trading VolumeSIBNSI-BONE4.0648 of 5 stars$13.47flat$24.40+81.1%-14.5%$571.84M$167.18M-14.64350Positive NewsGap DownKIDSOrthoPediatrics4.3197 of 5 stars$21.80-4.0%$37.20+70.6%-31.1%$529.46M$204.73M-17.72200Positive NewsHigh Trading VolumeBFLYButterfly Network1.5188 of 5 stars$2.08+1.7%$3.00+44.6%+168.4%$504.07M$82.06M-4.51460Gap Down Remove Ads Related Companies and Tools Related Companies AxoGen Competitors Embecta Competitors Bioventus Competitors RxSight Competitors CeriBell Competitors Iradimed Competitors Avanos Medical Competitors SI-BONE Competitors OrthoPediatrics Competitors Butterfly Network Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NYXH) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredThis story is about to go viralThis Story Could Go Viral as Soon as May 31 Quietly, towns like Shreveport, Louisiana and Fort Worth, Texas...Stansberry Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | SponsoredTrump’s betrayal exposed Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nyxoah S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nyxoah With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NYXH Stock Free NYXH Stock Alerts